Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.53 USD | +1.65% |
|
+9.08% | -33.96% |
Jun. 28 | Sector Update: Health Care Stocks Edge Higher in Afternoon Trading | MT |
Jun. 28 | Mizuho Securities Cuts Price Target on Apellis Pharmaceuticals to $49 From $52, Maintains Neutral Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.96% | 4.8B | |
+6.96% | 101B | |
+8.29% | 42.63B | |
-11.09% | 33.5B | |
+82.32% | 29.77B | |
-11.82% | 16.14B | |
+1.39% | 14.31B | |
-12.13% | 11.55B | |
+176.65% | 10.53B | |
+6.74% | 9.2B |
- Stock Market
- Equities
- APLS Stock
- News Apellis Pharmaceuticals, Inc.
- Transcript : Apellis Pharmaceuticals, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-12-2021 07